to 97). Major causes included malignant disorders (n=100; 69%), primary hyperparathyroidism (n=31; 21%), vitamin D-induced (n= 4; 3%), and miscellaneous or unknown cause in 11 (8%). Among malignant disorders, adult T cell leukemia was the most frequent (n=35), being followed by lung cancer (n=25). Breast carcinoma was less prevalent (n=4).
Introduction

Hypercalcemia is defined as an abnormal elevation in serum calcium concentration (1). Many different disorders can cause hypercalcemia (2). The most common categories among hospitalized patients are malignancy, primary hyperparathyroidism (PHP) and vitamin D-induced hypercalcemia (3, 4). The less frequent causes include other drug-induced conditions (thiazide diuretics, lithium, etc), tuberculosis, immobilization, and recovery phase of rhabdomyolysis. Identification of the underlying disease is important, since the subsequent management is different for the various causes of hypercalcemia.
Although detailed medical history, physical examination, and carefully directed laboratory measurements can differentiate the causes in most cases, hypercalcemia remains a challenging problem for general internists especially during the initial step of diagnostic evaluation. When facing a newly admitted patient with hypercalcemia of unknown etiology, it is important to consider the relative frequency of several main causes (5). Although a few previous studies have addressed geographic variations on international perspective, few reports are available about Asian populations.
Thus, our objective was to determine the causes and relative prevalence of hypercalcemia in Japanese patients. Additionally, we compared the causes of hypercalcemia found in this study to those reported from other parts of Japan and from T a b l e 1 . Ca u s e s a n d Re l a t i v e P r e v a l e n c e o f Hy p e r c a l c e mi a ( N= 1 4 
Patients and Methods
Study patients
We reviewed adult patients (16 years (10) . (11) (12) (13) (14) and to determine specific and effective anti-tumor therapy (6) .
Statistical analysis
We calculated the overall incidence and relative prevalence of different causes of hypercalcemia with 95% confidence interval (CI). We compared clinical laboratory data between PHP and hypercalcemia of malignancy. We presented the laboratory values as the mean ± standard deviation (SD). Non-parametric tests (Wilcoxon tests
)
T a b l e 2 . Di s t r i b u t i o n o f T u mo r T y p e s a mo n g Di f f e r e n t S e r i e s o f Hy p e r c a l c e mi a o f Ma l i g n a n c y T a b l e 3 . L a b o r a t o r y Da t a b e t we e n P a t i e n t s wi t h Hy p e r c a l c e mi a o f Ma l i g n a c y a n d P HP
Discussion
The major causes of hypercalcemia were found to be malignancy and PHP in Okinawan Japanese patients. Hypercalcemia was infrequent among hospitalized patients. Additionally, the present study showed the different etiologic prevalence of hypercalcemia of malignancy in Eastern patients compared to that in Western patients. The relative prevalence of malignancy-related hypercalcemia seemed to reflect the relative prevalence of malignancy in the local population. It is essential to detect the primary tumor in patients with hypercalcemia of malignancy to predict the prognosis
Hematologic diseases, especially adult T cell leukemia/ lymphoma (ATL), were the most frequent type among malignancy-related hypercalcemia in our hospital in Okinawa, Japan. With an unusually high association of hypercalcemia, about 40% of patients with ATL are known to eventually develop hypercalcemia (15, 16) . On the other hand, breast carcinoma was relatively uncommon in our series as well as in other Asian studies (9, 10) , in contrast to Western series with this carcinoma typically accounting for more than 20% (3, 6, (17) (18) (19) . The low prevalence of hypercalcemia due to breast carcinoma may reflect the low incidence of this tumor in Asia (9) , while the high prevalence of hypercalcemia due to ATL may be due to the high incidence of this hematologic malignancy in Okinawa and southern areas of Japan (20) (21) (22) (23) . Furthermore, ATL is more prevalent in the southern area of Japan than in northern areas (24) . Thus, the etiologic prevalence of hypercalcemia in other parts of Japan, especially the northern areas such as Hokkaido and Tohoku, can be quite different from that of the present study conducted in Okinawa (25) .
Many previous studies of the hypercalcemia of malignancy have presented important sites of malignancy along with relative prevalence (3, 6, 12, 13, (17) (18) (19) 26 (27) . Because this study was performed using hospitalized patients, only about 15% had PHP. PHP is known to be the most common etiology for hypercalcemia in the outpatient setting (28, 29 (28) . A study in Norway also noted a high prevalence of primary hyperparathyroidism in older women (29) .
On the other hand, one study, reported from a hospitalized population in Hong Kong, showed that PHP was relatively uncommon (5.5%) (9) . Two reports from Taiwan also noted this point (10, 30 We detected no cases of granulomatous diseases. Sarcoidosis was relatively rare but its incidence has recently increased in the northern part of Japan (31) . The reason may be that our site, located in southern part of Japan, has a low prevalence of sarcoidosis in general. Tuberculosis was shown to be an important cause of hypercalcemia in two Hong Kong studies (9, 32) , although the present study found no case of tuberculosis. Another reason for these variations may be the time of data collection, since the incidence of granulomatous diseases may fluctuate over time (33) .
The immunoradiometric assay for iPTH provides adequate discrimination to diagnose PHP (34) , while PTHrP is the most useful analysis method in the majority of patients with hypercalcemia of malignancy (35) . In the era of technological improvements employing iPTH and PTHrP assays, we propose the diagnostic strategy to routinely measure iPTH for newly identified patients with hypercalcemia (36) . This strategy may also be advised when evaluating patients with hypercalcemia of malignancy, since some patients with malignancy may possibly develop PHP at a higher rate than the general population (37, 38) . One patient in our study had such an etiologic combination.
Although several common laboratory values such as the chloride phosphate ratio and serum albumin may serve as a guide for the differential diagnosis between PHP and hypercalcemia of malignancy (39, 40) , our data showed these values were less specific. Incorrect classification remained a significant problem, although 80 percent discrimination could be achieved by the chloride phosphate ratio and serum albumin using logistic regression analysis in our study. These laboratory tests are not as precise as to the iPTH and PTHrP assays (41, 42) .
There 
